Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -51.11%41.61M | -12.77%113.5M | 10.89%85.11M | -19.88%130.11M | -6.20%76.75M | 24.17%162.39M | 54.41%81.82M | 62.15%130.77M | 96.42%52.99M | -29.83%80.65M |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | 36.36%-13.57M | ---- | -44.53%-21.32M | ---- | -199.01%-14.75M | ---- | -24.38%14.9M | ---- | 139.24%19.71M | ---- |
| Impairment and provisions: | ---- | 2,602.85%11.38M | --3M | -96.60%421K | ---- | 217.55%12.38M | ---- | 590.31%3.9M | ---- | -133.82%-795K |
| -Impairment of property, plant and equipment (reversal) | ---- | --4M | ---- | ---- | ---- | ---- | ---- | --2.84M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 940.14%4.38M | ---- | -96.60%421K | ---- | 1,064.44%12.38M | ---- | 233.71%1.06M | ---- | -2,048.65%-795K |
| -Other impairments and provisions | ---- | --3M | --3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 50.85%-3.74M | -180.14%-9.07M | -204.85%-7.61M | -454.45%-3.24M | -165.64%-2.5M | 86.55%-584K | 70.01%-940K | -768.20%-4.34M | -305.10%-3.13M | 99.11%-500K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --590K |
| -Loss (gain) on sale of property, machinery and equipment | 75.73%-381K | -199.60%-3.03M | -481.48%-1.57M | -73.12%-1.01M | 71.28%-270K | 86.55%-584K | 70.01%-940K | -298.26%-4.34M | -305.10%-3.13M | 98.07%-1.09M |
| -Loss (gain) from selling other assets | 44.39%-3.36M | -171.31%-6.04M | -171.31%-6.04M | ---2.23M | ---2.23M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 3.90%166.66M | ---- | -7.38%160.4M | ---- | 3.76%173.19M | ---- | 8.60%166.91M | ---- | 15.80%153.69M |
| -Amortization of intangible assets | ---- | 0.09%12.72M | ---- | -4.88%12.71M | ---- | -1.46%13.36M | ---- | 6.33%13.56M | ---- | -0.05%12.75M |
| -Other depreciation and amortization | ---- | -580.50%-12.25M | ---- | 12.20%-1.8M | ---- | -26.39%-2.05M | ---- | -67.74%-1.62M | ---- | 73.33%-967K |
| Special items | 15.06%86.61M | ---- | -8.19%75.28M | ---- | -1.64%81.99M | ---- | 52.20%83.36M | ---- | -14.84%54.77M | ---1.98M |
| Adjustment items | ---- | -580.50%-12.25M | ---- | 12.20%-1.8M | ---- | -26.39%-2.05M | ---- | -67.74%-1.62M | ---- | 73.33%-967K |
| Operating profit before the change of operating capital | -17.51%110.91M | -5.48%270.22M | -4.98%134.45M | -17.21%285.9M | -21.02%141.49M | 16.81%345.32M | 44.09%179.14M | 28.47%295.62M | 23.03%124.33M | 21.08%230.1M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 423.86%2.99M | -23.33%825K | 170.54%570K | -77.74%1.08M | 74.95%-808K | -7.45%4.83M | -174.90%-3.23M | 1,626.90%5.22M | --4.31M | 37.70%-342K |
| Accounts receivable (increase)decrease | 7.72%-98.14M | -44.16%-133.58M | 10.02%-106.34M | -81.99%-92.66M | 28.78%-118.19M | -186.29%-50.91M | -112.51%-165.94M | 49.67%59M | -305.27%-78.09M | 86.59%39.42M |
| Accounts payable increase (decrease) | 33.20%-9.43M | -366.74%-115.83M | -121.73%-14.12M | 29.40%43.42M | -48.65%64.96M | 175.72%33.56M | 196.35%126.52M | 66.49%-44.32M | 188.93%42.69M | -530.46%-132.24M |
| Cash from business operations | -56.50%6.33M | -90.90%21.64M | -83.35%14.56M | -28.56%237.74M | -35.92%87.46M | 5.48%332.8M | 46.39%136.49M | 130.40%315.52M | 176.00%93.24M | -27.79%136.94M |
| Hong Kong profits tax paid | ---- | 36.16%-4.16M | ---- | 54.65%-6.52M | ---- | -1,557.35%-14.38M | ---- | 105.82%987K | ---- | -118.74%-16.95M |
| China income tax paid | ---- | -46.76%-18.21M | ---- | 21.71%-12.41M | ---- | -0.91%-15.85M | ---- | 15.95%-15.71M | ---- | -44.28%-18.69M |
| Other taxs | -80.06%-9M | ---1.01M | 32.48%-5M | ---- | 17.50%-7.4M | ---- | -2,401.28%-8.98M | ---- | 103.58%390K | 43.01%-1.53M |
| Net cash from operations | -127.91%-2.67M | -100.80%-1.75M | -88.06%9.56M | -27.68%218.81M | -37.22%80.06M | 0.59%302.56M | 36.19%127.51M | 201.48%300.8M | 309.19%93.63M | -39.99%99.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -3.87%15.12M | ---- | 31.77%15.73M | ---- | 18.73%11.93M | ---- | -55.00%10.05M | ---- | -16.51%22.34M |
| Dividend received - investment | ---- | 174.60%19.7M | ---- | -11.06%7.17M | ---- | -61.31%8.07M | ---- | 64.14%20.84M | ---- | -92.79%12.7M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 0.00%1.22M | --1.22M | -48.53%1.22M | ---- | -72.33%2.38M |
| Decrease in deposits (increase) | -117.73%-3.72M | -86.35%-40.82M | 165.75%20.98M | 29.79%-21.9M | ---31.91M | -113.11%-31.2M | ---- | 38.89%238.05M | 166,494.37%236.56M | 304.13%171.39M |
| Sale of fixed assets | -24.38%1.68M | 302.42%4.32M | 481.36%2.22M | -49.93%1.07M | -81.38%381K | -53.99%2.14M | -46.34%2.05M | 79.57%4.66M | --3.81M | -96.37%2.59M |
| Purchase of fixed assets | 1.34%-31.98M | -135.87%-110.04M | -44.52%-32.41M | 57.42%-46.65M | 68.93%-22.43M | 40.71%-109.57M | 26.98%-72.18M | 27.40%-184.79M | 9.59%-98.84M | -67.42%-254.52M |
| Purchase of intangible assets | ---- | ---3.22M | ---- | ---- | ---- | ---9.44M | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | 262.32%17.41M | 262.32%17.41M | --4.8M | --4.8M | ---- | ---- | ---- | ---- | ---5.04M |
| Acquisition of subsidiaries | --6.38M | ---123.4M | ---- | ---- | ---- | ---- | ---- | 7.14%-152M | ---- | ---163.68M |
| Cash on investment | ---180.86M | ---- | ---- | ---4.98M | ---- | ---- | ---- | ---- | ---- | 92.21%-2.3M |
| Other items in the investment business | -15.54%12.04M | ---- | 65.24%14.26M | ---- | 51.59%8.63M | ---- | -43.49%5.69M | ---- | 106.69%10.08M | ---- |
| Net cash from investment operations | -975.27%-196.46M | -393.59%-220.94M | 155.39%22.45M | 64.71%-44.76M | 35.90%-40.52M | -104.70%-126.84M | -141.70%-63.21M | 71.07%-61.96M | 158.38%151.61M | -1,448.20%-214.15M |
| Net cash before financing | -722.15%-199.13M | -227.95%-222.69M | -19.04%32.01M | -0.96%174.04M | -38.51%39.54M | -26.43%175.73M | -73.78%64.3M | 308.82%238.84M | 203.55%245.24M | -162.79%-114.38M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 32.69%374.71M | --281.8M | --282.4M | ---- | ---- | -94.70%20M | ---- | 126.95%377.17M | -38.63%100M | 232.38%166.19M |
| Refund | 27.44%-207.21M | -505.25%-296.26M | -1,544.54%-285.56M | 28.22%-48.95M | -176.10%-17.36M | 66.63%-68.19M | 95.11%-6.29M | -37.77%-204.34M | -531.43%-128.63M | -23.38%-148.32M |
| Interest paid - financing | ---- | 17.76%-19.12M | ---- | 3.61%-23.25M | ---- | -109.60%-24.12M | ---- | -13.76%-11.51M | ---- | 18.43%-10.12M |
| Dividends paid - financing | 20.00%-44.85M | -26.91%-85.37M | ---56.06M | -200.00%-67.27M | ---- | 40.34%-22.42M | 29.00%-22.42M | -11.73%-37.58M | 6.10%-31.58M | 68.42%-33.64M |
| Other items of the financing business | -6.92%-27.95M | 1,204.56%159.47M | 39.53%-26.14M | ---14.44M | -74.04%-43.24M | ---- | -50.45%-24.84M | ---- | 3.28%-16.51M | ---- |
| Net cash from financing operations | 210.94%94.7M | 107.75%14.32M | -40.87%-85.36M | -35.47%-184.76M | -13.15%-60.6M | -258.47%-136.39M | 30.20%-53.55M | 282.77%86.07M | -183.51%-76.72M | 77.75%-47.09M |
| Effect of rate | 1,164.07%18.42M | 29.56%-25.3M | 91.89%-1.73M | 30.99%-35.92M | -21.45%-21.34M | -786.58%-52.05M | -62,846.43%-17.57M | -132.17%-5.87M | 101.12%28K | 378.04%18.25M |
| Net Cash | -95.72%-104.43M | -1,844.37%-208.38M | -153.32%-53.36M | -127.24%-10.72M | -296.06%-21.06M | -87.89%39.34M | -93.62%10.74M | 301.23%324.9M | 216.25%168.52M | -447.41%-161.46M |
| Begining period cash | -23.71%752.06M | -4.52%985.74M | -4.52%985.74M | -1.22%1.03B | -1.22%1.03B | 43.94%1.05B | 43.94%1.05B | -16.48%726.06M | -16.48%726.06M | -3.98%869.27M |
| Cash at the end | -28.43%666.05M | -23.71%752.06M | -5.99%930.65M | -4.52%985.74M | -4.65%989.97M | -1.22%1.03B | 16.06%1.04B | 43.94%1.05B | 23.94%894.6M | -16.48%726.06M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.